Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 7/24/18 (What's New)

Summary

  • For most patients, currently available regimens  are all-oral, highly effective, well tolerated, and require short treatment durations
  • For select patient groups, virologic response rates remain suboptimal even with newly approved DAAs

Action required